Log In
Print this Print this

Oral respiratory syncytial virus (RSV) vaccine

  Manage Alerts
Collapse Summary General Information
Company Vaxart Inc.
DescriptionF-protein-based respiratory syncytial virus (RSV) tablet vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsPrevent respiratory syncytial virus (RSV) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today